Listar MED_Articles por fuente "Cancers. 2022; 14 (5): 1146."
Mostrando ítems 1-1 de 1
-
Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients
MDPI (2022-03-01)Background: Paclitaxel is a microtubule-stabilizing chemotherapeutic agent. Despite its widespread use, it damages healthy tissues such as skin. The goal of this study was to prove that the real impact of paclitaxel-induced ...